ACE and cystic fibrosis: Given the absence of CF, the etiology of the disease in this patient remains unclear; however, the use of an angiotensin-converting enzyme (ACE) inhibitor is hypothesized to have contributed to the onset of symptoms through mechanical mechanisms involving sodium retention and osmotic gradient disruption in keratinocytes.